Items where authors include "Bergmann, C."

Article

Masoud, S., Wong, K., Pitcher, D. et al. (268 more authors) (2025) Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranous proliferative glomerulonephritis using the United Kingdom RaDaR Registry. Kidney International. ISSN 0085-2538

Masoud, S., Wong, K., Pitcher, D. et al. (269 more authors) (2025) Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranous proliferative glomerulonephritis using the United Kingdom RaDaR Registry. Kidney International. ISSN 0085-2538 (In Press)

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (60 more authors) (2025) A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology. keaf053. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Soderstrom, M., Rocha-Hidalgo, J., Muñoz, L. E. et al. (39 more authors) (2024) Testing the Relationship Between Preferences for Infant-Directed Speech and Vocabulary Development: A Multi-Lab Study. Journal of Child Language. ISSN 0305-0009

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Wong, K., Pitcher, D., Braddon, F. et al. (299 more authors) (2024) Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort. Kidney International Reports, 9 (7). pp. 2067-2083. ISSN 2468-0249

Wong, K., Pitcher, D., Braddon, F. et al. (299 more authors) (2024) Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of rare kidney diseases cohort. Kidney International Reports, 9 (7). pp. 2067-2083. ISSN 2468-0249

Wong, K., Pitcher, D., Braddon, F. et al. (294 more authors) (2024) Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. The Lancet, 403 (10433). pp. 1279-1289. ISSN 0140-6736

Wong, K., Pitcher, D., Braddon, F. et al. (294 more authors) (2024) Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. The Lancet, 403 (10433). pp. 1279-1289. ISSN 0140-6736

Conference or Workshop Item

Roth, E., Bruni, C., Petelytska, L. et al. (18 more authors) (2024) POS0230 Characteristics and disease course of SSc-ILD patients with gastroesophageal reflux – an analysis of the EUSTAR cohort. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Proceedings Paper

Burja, B., Boubaya, M., Bruni, C. et al. (21 more authors) (2025) OP0081 Anti-Ro/SSA+/RF+ double seropositivity in systemic sclerosis is associated with more severe interstitial lung disease: A study from the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 71-72.

Benfaremo, D., Campochiaro, C., Kumánovics, G. et al. (16 more authors) (2025) OP0085 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , p. 75.

Burja, B., Boubaya, M., Bruni, C. et al. (21 more authors) (2025) OP0081 Anti-Ro/SSA+/RF+ double seropositivity in systemic sclerosis is associated with more severe interstitial lung disease: A study from the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. , pp. 71-72.

Benfaremo, D., Campochiaro, C., Kumanovics, G. et al. (16 more authors) (2025) OP0085 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. , p. 75.

Burja, B., Boubaya, M., Bruni, C. et al. (16 more authors) (2024) OP0013 ANTI-Ro/SSA ANTIBODIES ARE PREDICTIVE OF A MORE SEVERE LUNG INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR HDATABASE. In: Annals of the Rheumatic Diseases. EULAR 2024 Congress, 12-15 Jun 2025, Vienna, Austria. Elsevier , pp. 1-2.